MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1720-1726

  Naito, Yutaka ^a   Yasuno, Kyohei ^b   Tagawa, Hiroko ^b   Sakamoto, Naoya ^a   Oue, Naohide ^a   Yashiro, Masakazu ^c   Sentani, Kazuhiro ^a   Goto, Keisuke ^a   Shinmei, Shunsuke ^a   Oo, Htoo Zarni ^a   Yanagihara, Kazuyoshi ^d   Hirakawa, Kosei ^c   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

Author keywords

Fibroblast; MicroRNA 145; Scirrhous type gastric cancer; Transforming growth factor ; smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MICRORNA 145; TRANSFORMING GROWTH FACTOR BETA; MICRORNA; MIRN145 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ALPHA SMA GENE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL ACTIVATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; ADENOCARCINOMA; CANCER GRADING; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA, SCIRRHOUS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84921455833     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3333     Document Type: Article

References (36)

1. Otsuji E, Kuriu Y, Okamoto K, et al: Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg 188: 327-332, 2004. (Pubitemid 39278295)
2. Ikeguchi M, Miyake T, Matsunaga T, et al: Recent results of therapy for scirrhous gastric cancer. Surg Today 39: 290-294, 2009.
3. Yashiro M and Hirakawa K: Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron 3: 127-135, 2010.
4. Yamamoto M, Sumiyoshi H, Nakagami K, Taniyama K and Tahara E: Distribution of collagen types I and III and basal lamina in human gastric carcinoma: an immunohistochemical and electron microscopic study. Virchows Arch A Pathol Anat Histopathol 403: 313-322, 1984. (Pubitemid 14117583)
5. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M and Tahara E: Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398, 1989. (Pubitemid 19229293)
6. Jain RK: Barriers to drug delivery in solid tumors. Sci Am 271: 58-65, 1994.
7. Heldin CH, Rubin K, Pietras K and Ostman A: High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 4: 806-813, 2004. (Pubitemid 39331152)
8. NakajimaTE, Yanagihara K, Takigahira M, et al: Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan. Cancer Res 68: 9318-9322, 2008.
9. Worthley DL, Giraud AS and Wang TC: The extracellular matrix in digestive cancer. Cancer Microenviron 3: 177-185, 2010.
10. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
12. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
13. Naito Y, Sakamoto N, Oue N, et al: MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci 105: 228-235, 2014.
14. Cordes KR, Sheehy NT, White MP, et al: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710, 2009.
15. Iio A, Nakagawa Y, Hirata I, Naoe T and Akao Y: Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol Cancer 9: 136, 2010.
16. Long X and Miano JM: Transforming growth factor-β1 (TGF-β1) utilized distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem 286: 30119-30129, 2011.
17. Ochiai A, Yasui W, Kameda T, Takanashi A, Takekura N and Tahara E: The effect of phorbol esters on cell growth and epidermal growth factor receptor modulation in a human gastric carcinoma cell line TMK-1. Hiroshima J Med Sci 38: 191-195, 1989. (Pubitemid 20167193)
18. Yanagihara K, Seyama T, Tsumuraya M, Kamada N and Yokoro K: Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 51: 381-386, 1991.
19. Yanagihara K, Tanaka H, Takigahira M, et al: Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 95: 575-582, 2004. (Pubitemid 39089638)
20. Fuyuhiro Y, Yashiro M, Noda S, et al: Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells. Cancer Sci 103: 797-805, 2012.
21. Naito Y, Oue N, Hinoi T, et al: Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer. PLoS One 7: e47545, 2012.
22. Kondo T, Oue N, Yoshida K, et al: Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 64: 523-529, 2004. (Pubitemid 38120891)
23. Shinmei S, Sakamoto N, Goto K, et al: MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma. Int J Urol 20: 468-477, 2013.
24. Yasui W, Ayhan A, Kitadai Y, et al: Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 53: 36-41, 1993. (Pubitemid 23018419)
25. Ueda T, Volinia S, Okumura H, et al: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146, 2010.
26. Liu L, Chen Q, Lai R, et al: Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer. J Biomed Res 24: 187-197, 2010.
27. Gao P, Xing AX, Zhou GY, et al: The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 32: 491-501, 2013.
28. Zheng L, Pu J, Qi T, et al: miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol Cancer Res 11: 182-193, 2013.
29. Ostenfeid MS, Bramsen JB, Lamy P, et al: miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 29: 1073-1084, 2010.
30. Hamano R, Miyata H, Yamasaki M, et al: Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the akt signaling pathway. Clin Cancer Res 17: 3029-3038, 2011.
31. Villadsen SB, Bramsen JB, Ostenfeld MS, et al: The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer 106: 366-374, 2012.
32. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
33. Yang S, Cui H, Xie N, et al: miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB J 27: 2382-2391, 2013.
34. Mahara K, Kato J, Terui T, et al: Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. Br J Cancer 69: 777-783, 1994. (Pubitemid 24112705)
35. Kawajiri H, Yashiro M, Shinto O, et al: A novel transforming growth factor β receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 14: 2850-2860, 2008.
36. Shinto O, Yashiro M, Kawajiri H, et al: Inhibitory effect of a TGF β receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer 102: 844-851, 2010.